These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27993849)

  • 21. In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem.
    Oleksiuk LM; Nguyen MH; Press EG; Updike CL; O'Hara JA; Doi Y; Clancy CJ; Shields RK
    Antimicrob Agents Chemother; 2014; 58(2):1195-9. PubMed ID: 24247139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptomic analysis of colistin-susceptible and colistin-resistant isolates identifies genes associated with colistin resistance in Acinetobacter baumannii.
    Park YK; Lee JY; Ko KS
    Clin Microbiol Infect; 2015 Aug; 21(8):765.e1-7. PubMed ID: 25911992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance.
    Wand ME; Bock LJ; Bonney LC; Sutton JM
    J Antimicrob Chemother; 2015 Aug; 70(8):2209-16. PubMed ID: 25904728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment.
    Snitkin ES; Zelazny AM; Gupta J; ; Palmore TN; Murray PR; Segre JA
    Genome Res; 2013 Jul; 23(7):1155-62. PubMed ID: 23564252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
    Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain.
    López-Rojas R; Jiménez-Mejías ME; Lepe JA; Pachón J
    J Infect Dis; 2011 Oct; 204(7):1147-8. PubMed ID: 21881133
    [No Abstract]   [Full Text] [Related]  

  • 27. Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation.
    Dafopoulou K; Xavier BB; Hotterbeekx A; Janssens L; Lammens C; Dé E; Goossens H; Tsakris A; Malhotra-Kumar S; Pournaras S
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1892-5. PubMed ID: 26666921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
    Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R
    Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
    Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.
    Li J; Rayner CR; Nation RL; Owen RJ; Spelman D; Tan KE; Liolios L
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2946-50. PubMed ID: 16940086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Genes Involved in Colistin Resistance in
    Al-Kadmy IMS; Ibrahim SA; Al-Saryi N; Aziz SN; Besinis A; Hetta HF
    Microb Drug Resist; 2020 Jun; 26(6):616-622. PubMed ID: 31816255
    [No Abstract]   [Full Text] [Related]  

  • 33. Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin.
    Rodriguez CH; Bombicino K; Granados G; Nastro M; Vay C; Famiglietti A
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):188-91. PubMed ID: 19748431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment.
    Kim Y; Bae IK; Lee H; Jeong SH; Yong D; Lee K
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):362-6. PubMed ID: 24809861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquisition of Tn6018-3' CS regions increases colistin MICs against Acinetobacter baumannii isolates harboring new variants of AbaRs.
    Savari M; Ekrami A; Shoja S; Bahador A
    Folia Microbiol (Praha); 2017 Sep; 62(5):373-379. PubMed ID: 28238067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W; Munsrichoom A; Srisarang S; Treeratweeraphong V
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.
    Nepka M; Perivolioti E; Kraniotaki E; Politi L; Tsakris A; Pournaras S
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6903-6906. PubMed ID: 27550356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii.
    Kempf M; Djouhri-Bouktab L; Brunel JM; Raoult D; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):180-1. PubMed ID: 22100281
    [No Abstract]   [Full Text] [Related]  

  • 39. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.
    Al-Sweih NA; Al-Hubail MA; Rotimi VO
    J Chemother; 2011 Feb; 23(1):13-6. PubMed ID: 21482488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
    Seifert H; Stefanik D; Sutcliffe JA; Higgins PG
    Int J Antimicrob Agents; 2018 Jan; 51(1):62-64. PubMed ID: 28705668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.